Insider · CIK 0001743879
Ming Xian
Files at MED (MEDIFAST INC). First filing -, latest -.
In brief
Ming Xian files SEC Form 4 as director at MED (MEDIFAST INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ming Xian has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | MED MEDIFAST INC | AGrant or award Restricted Stock Units (cash settled)derivative | +11,680 | $0.00 | $0 | 43,823 | May 28, 2026 |
| Jun 25, 2025 | MED MEDIFAST INC | AGrant or award Restricted Stock Units (cash settled)derivative | +11,168 | $0.00 | $0 | 26,130 | Jun 26, 2025 |
| Jun 25, 2025 | MED MEDIFAST INC | AGrant or award Restricted Stock Units (cash settled)derivative | +6,013 | $13.39 | $81k | 32,143 | Jun 26, 2025 |
Questions about Ming Xian
Answered from the filings on this page, as of the latest one.
Is Ming Xian buying or selling?
Ming Xian has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ming Xian's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ming Xian has 0.
Where does Ming Xian file Form 4?
Ming Xian has filed Form 4 at MED (MEDIFAST INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.